Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Deniz Lengerli, Kübra Ibis, Yahya Nural & Erden Banoglu. (2022) The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool. Expert Opinion on Drug Discovery 17:11, pages 1209-1236.
Read now
Read now
Jorge Gómez-Carpintero, Clara Cabrero, Juan Domingo Sánchez, Juan Francisco González & José Carlos Menéndez. (2022) A sequential multistep process for the fully mechanochemical, one-pot synthesis of the antiepileptic drug rufinamide. Green Chemistry Letters and Reviews 15:3, pages 638-645.
Read now
Read now
Barnali Maiti, Balamurali M M & Kaushik Chanda. (2019) Evaluation of WO2014121383 A1: a process for preparation of rufinamide and intermediates. Expert Opinion on Therapeutic Patents 29:1, pages 7-10.
Read now
Read now
Baira Shandilya Mahamuni, R. Srinivas & M.V.N Kumar Talluri. (2018) Characterization of Forced Degradation Products of Rufinamide by LC/QTOF/MS/MS, NMR and IR studies. Analytical Chemistry Letters 8:3, pages 405-415.
Read now
Read now
Rajeev Kharb, Prabodh Chander Sharma & Mohammed Shahar Yar. (2011) Pharmacological significance of triazole scaffold. Journal of Enzyme Inhibition and Medicinal Chemistry 26:1, pages 1-21.
Read now
Read now
Tiziana Granata, Nicola Marchi, Erin Carlton, Chaitali Ghosh, Jorge Gonzalez-Martinez, Andreas V Alexopoulos & Damir Janigro. (2009) Management of the patient with medically refractory epilepsy. Expert Review of Neurotherapeutics 9:12, pages 1791-1802.
Read now
Read now
Yan Xiao, Caifeng Bi, Yuhua Fan, Shanbing Liu, Xia Zhang, Dongmei Zhang, Yilong Wang & Rong Zhu. (2009) Synthesis, characterization and bioactivity of Schiff base copper(II) complexes derived from L-glutamine and L-asparagine. Journal of Coordination Chemistry 62:18, pages 3029-3039.
Read now
Read now
Danielle M Andrade, Clement Hamani & Berge A Minassian. (2009) Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus. Expert Opinion on Pharmacotherapy 10:10, pages 1549-1560.
Read now
Read now
Kenou van Rijckevorsel. (2008) Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatric Disease and Treatment 4:6, pages 1001-1019.
Read now
Read now
Articles from other publishers (66)
Walaa Hamada Abd-Allah, Mostafa Abd El-Mohsen Anwar, Eman R. Mohammed & Samir M. El Moghazy. (2023) Anticonvulsant Classes and Possible Mechanism of Actions. ACS Chemical Neuroscience 14:23, pages 4076-4092.
Crossref
Crossref
Renzo Carlucci, María-Natalia Lisa & Guillermo R. Labadie. (2023) 1,2,3-Triazoles in Biomolecular Crystallography: A Geometrical Data-Mining Approach. Journal of Medicinal Chemistry 66:21, pages 14377-14390.
Crossref
Crossref
Jamir Pitton Rissardo, Nilofar Vora, Bejoi Mathew, Vikas Kashyap, Sara Muhammad & Ana Letícia Fornari Caprara. (2023) Overview of Movement Disorders Secondary to Drugs. Clinics and Practice 13:4, pages 959-976.
Crossref
Crossref
Pavel S. Silaichev, Tetyana V. Beryozkina, Vladimir Ilkin, Mikhail S. Novikov, Wim Dehaen & Vasiliy A. Bakulev. (2023)
Tandem Cycloaddition of Azides to 3,3-Diaminoacrylonitriles (2-Cyanoacetamidines) and Cornforth-Type Rearrangement as an Approach to 5-Amino-1,2,3-triazole-4-
N
-substituted Imidamides
. The Journal of Organic Chemistry 88:13, pages 8163-8174.
Crossref
Crossref
Zubin Singh Rana, Reena Suman, Shobi Veleri & Pradeep Punnakkal. (2023) Mechanism of Anti-seizure Medications and Emerging Trends in Epilepsy Treatment. International Journal of Drug Discovery and Pharmacology.
Crossref
Crossref
Muhammad Ikram & Sufian Rasheed. (2023) Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine:
A Roadmap for Future Treatment of Drug Resistant Seizures. Current Molecular Pharmacology 16:4, pages 475-493.
Crossref
Crossref
Konrad Kowalski. (2023) A brief survey on the application of metal-catalyzed azide–alkyne cycloaddition reactions to the synthesis of ferrocenyl-x-1,2,3-triazolyl-R (x = none or a linker and R = organic entity) compounds with anticancer activity. Coordination Chemistry Reviews 479, pages 214996.
Crossref
Crossref
Xiaojing Pang, Hua Li & Lixia Chen. 2023. Privileged Scaffolds in Drug Discovery. Privileged Scaffolds in Drug Discovery
105
115
.
Disha P. Vala, Ruturajsinh M. Vala & Hitendra M. Patel. (2022) Versatile Synthetic Platform for 1,2,3-Triazole Chemistry. ACS Omega 7:42, pages 36945-36987.
Crossref
Crossref
Dawid Drelinkiewicz & Richard J. Whitby. (2022) A practical flow synthesis of 1,2,3-triazoles. RSC Advances 12:45, pages 28910-28915.
Crossref
Crossref
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, Hesham A. M. Gomaa & Bahaa G. M. Youssif. (2022) New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase. Archiv der Pharmazie 355:6.
Crossref
Crossref
Adriana D. Oprea, Maureen C. Keshock, Avital Y. O’Glasser, Kenneth C. CummingsIIIIII, Angela F. Edwards, Andrea Leep Hunderfund, Richard D. Urman & Karen F. Mauck. (2022) Preoperative Management of Medications for Neurologic Diseases. Mayo Clinic Proceedings 97:2, pages 375-396.
Crossref
Crossref
Suman Yadav, Noor U Din Reshi, Saikat Pal & Jitendra K. Bera. (2021) Aerobic oxidation of primary amines to amides catalyzed by an annulated mesoionic carbene (MIC) stabilized Ru complex. Catalysis Science & Technology 11:21, pages 7018-7028.
Crossref
Crossref
Thais B. Silva, Kathya N.K. Ji, Fernanda Petzold Pauli, Raíssa M.S. Galvão, Ana F.M. Faria, Murilo L. Bello, Jackson A.L.C. Resende, Vinicius R. Campos, Luana da S.M. Forezi, Fernando de C. da Silva, Robson X. Faria & Vitor F. Ferreira. (2021) Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents. Bioorganic Chemistry 116, pages 105250.
Crossref
Crossref
Komuraiah Buduma, Niranjana Kumar A, Satya Srinivas KVN, Kotesh Kumar J, Srinivas Chinde, Anand Kumar Domatti, Yogesh Kumar, Paramjit Grover, Ashok Tiwari & Feroz Khan. (2021) Synthesis and bioactivity evaluation of eugenol hybrids obtained by Mannich and 1,3 dipolar cycloaddition reactions. Journal of Heterocyclic Chemistry 58:11, pages 2078-2089.
Crossref
Crossref
Pravin S. Kulkarni, Sanjay N. Karale, Amol U. Khandebharad, Brijmohan R. Agrawal & Swapnil R. Sarda. (2021) Synthesis of novel 1,2,3-triazoles bearing 2,4 thiazolidinediones conjugates and their biological evaluation. Journal of the Iranian Chemical Society 18:8, pages 2035-2046.
Crossref
Crossref
Frank M. C. Besag & Michael J. Vasey. (2021) Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy. Pediatric Drugs 23:3, pages 253-286.
Crossref
Crossref
Everton M. da Silva, Danilo Yano de Albuquerque, Julio Zukerman‐Schpector & Ricardo S. Schwab. (2021) Development of a Novel Three‐step Sonogashira Cross Coupling/Deacetonation/Cycloaddition Protocol for the Synthesis of 4‐aryl‐1,2,3‐triazoles Using 2‐methyl‐3‐butyn‐2‐ol as a Versatile Acetylene Surrogate. Asian Journal of Organic Chemistry 10:5, pages 1153-1160.
Crossref
Crossref
Marta Serafini, Tracey Pirali & Gian Cesare Tron. 2021. Applications of Heterocycles in the Design of Drugs and Agricultural Products. Applications of Heterocycles in the Design of Drugs and Agricultural Products
101
148
.
Zsolt Fülöp, Péter Szemesi, Péter Bana, János Éles & István Greiner. (2020) Evolution of flow-oriented design strategies in the continuous preparation of pharmaceuticals. Reaction Chemistry & Engineering 5:9, pages 1527-1555.
Crossref
Crossref
Mayuri Patil, Pradeep Mhaldar, Vrushali Mahadik & Dattaprasad M. Pore. (2020) Novel, green and sustainable route for synthesis of 5-aryl-4-phenyl-1,2,4-triazolidine-3-thiones. Tetrahedron Letters 61:25, pages 152015.
Crossref
Crossref
M. Shaheer Malik, Saleh A. Ahmed, Ismail I. Althagafi, Mohammed Azam Ansari & Ahmed Kamal. (2020) Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents. RSC Medicinal Chemistry 11:3, pages 327-348.
Crossref
Crossref
Pranesh PalPrathama S. Mainkar, Kiranmai Nayani & Srivari Chandrasekhar. (2020)
Mn-catalyzed radical initiated domino transformation of alkynylated cyclohexadienones with TMSN
3
and O
2
to bicyclic azido alcohols
. Chemical Communications 56:23, pages 3453-3456.
Crossref
Crossref
Archana Asatkar, Arijit Saha, Trimurti L. Lambat, Man Singh & Subhash Banerjee. (2020) Biomass rice husk derived activated carbon catalyzed synthesis of 5-aryl-1,2,4-triazolidine-3-thione derivatives under metal-free aqueous medium. Materials Today: Proceedings 29, pages 698-703.
Crossref
Crossref
Marc Escribà-Gelonch, Gerardo Antonio de Leon Izeppi, Dirk Kirschneck & Volker Hessel. (2019)
Multistep Solvent-Free 3 m
2
Footprint Pilot Miniplant for the Synthesis of Annual Half-Ton Rufinamide Precursor
. ACS Sustainable Chemistry & Engineering 7:20, pages 17237-17251.
Crossref
Crossref
Sangeetha Donikela, Prathama S. Mainkar, Kiranmai Nayani & Srivari Chandrasekhar. (2019) Metal Free Domino β-Azidation/[3 + 2] Cycloaddition Reaction for the Synthesis of 1,2,3-Triazole-Fused Dihydrobenzoxazinones. The Journal of Organic Chemistry 84:16, pages 10546-10553.
Crossref
Crossref
Rina Das, Gyati S. Asthana, Krishan A. Suri, Dinesh Mehta & Abhay Asthana. (2019) Recent Developments in Azole Compounds as Antitubercular Agent. Mini-Reviews in Organic Chemistry 16:3, pages 290-306.
Crossref
Crossref
К. Yu. Мukhin & О. A. Pylaeva. (2018) Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature). Russian Journal of Child Neurology 13:2, pages 20-33.
Crossref
Crossref
Shin Hye Kim, Hoon-Chul Kang, Joon Soo Lee & Heung Dong Kim. (2018) Rufinamide efficacy and safety in children aged 1–4 years with Lennox–Gastaut syndrome. Brain and Development 40:10, pages 897-903.
Crossref
Crossref
Jin-A Park & Choong-Hyun Lee. (2018) Effect of Rufinamide on the kainic acid-induced excitotoxic neuronal death in the mouse hippocampus. Archives of Pharmacal Research 41:7, pages 776-783.
Crossref
Crossref
Sathish Kumar Boda, Vasantha Pishka, P. V. Anantha Lakshmi, Srinivas Chinde & Paramjit Grover. (2018)
1,2,3-Triazole Tagged 3
H
-Pyrano[2,3-
d
]pyrimidine-6-carboxylate Derivatives: Synthesis,
in Vitro
Cytotoxicity, Molecular Docking and DNA Interaction Studies
. Chemistry & Biodiversity 15:6, pages e18000101.
Crossref
Crossref
Rebeca González‐Fernández, Pascale Crochet & Victorio Cadierno. (2018) Cymene‐Osmium(II) Complexes with Amino‐Phosphane Ligands as Precatalysts for Nitrile Hydration Reactions. ChemistrySelect 3:16, pages 4324-4329.
Crossref
Crossref
R. D. Padmaja & Kaushik Chanda. (2018) A Short Review on Synthetic Advances toward the Synthesis of Rufinamide, an Antiepileptic Drug. Organic Process Research & Development 22:4, pages 457-466.
Crossref
Crossref
Samir Diab & Dimitrios I. Gerogiorgis. (2018) Process modelling, simulation and technoeconomic evaluation of crystallisation antisolvents for the continuous pharmaceutical manufacturing of rufinamide. Computers & Chemical Engineering 111, pages 102-114.
Crossref
Crossref
Pasquale Striano, Rob McMurray, Estevo Santamarina & Mercè Falip. (2018) Rufinamide for the treatment of Lennox‐Gastaut syndrome: evidence from clinical trials and clinical practice. Epileptic Disorders 20:1, pages 13-29.
Crossref
Crossref
Nita Salunke, Rajesh Thipparaboina, Rahul B. Chavan, Anurag Lodagekar, Sudhir Mittapalli, Ashwini Nangia & Nalini R. Shastri. (2018) Rufinamide: Crystal structure elucidation and solid state characterization. Journal of Pharmaceutical and Biomedical Analysis 149, pages 185-192.
Crossref
Crossref
D. R. Meena, R. Nishanth Rao, Barnali Maiti & Kaushik Chanda. (2017) Novel Cu(I)-catalyzed one-pot multicomponent synthesis of the antiepileptic drug rufinamide. Research on Chemical Intermediates 43:8, pages 4711-4717.
Crossref
Crossref
Kuldeep Singh, Abir Sarbajna, Indranil Dutta, Pragati Pandey & Jitendra K. Bera. (2017)
Hemilability-Driven Water Activation: A Ni
II
Catalyst for Base-Free Hydration of Nitriles to Amides
. Chemistry - A European Journal 23:32, pages 7761-7771.
Crossref
Crossref
Helio G. Bonacorso, Gean M. Dal Forno, Carson Wiethan, Alex Ketzer, Nilo Zanatta, Clarissa P. Frizzo, Marcos A. P. Martins & Mark Stradiotto. (2017) Sequential one-pot three-step synthesis of polysubstituted 4-(5-(trifluoromethyl)-1H-pyrazol-4-yl)-1H-1,2,3-triazole systems. RSC Advances 7:69, pages 43957-43964.
Crossref
Crossref
Huijun Yuan, Lili Zhang, Zhantao Liu, Yang Liu, Jian Wang & Wenjun Li. (2017) A NHC-catalyzed 1,3-dipolar cycloaddition reaction of allyl ketones with azides: direct access to 1,4,5-trisubstituted 1,2,3-triazoles. Organic & Biomolecular Chemistry 15:20, pages 4286-4290.
Crossref
Crossref
N. J. P. Subhashini, K. Sravanthi, Ch. Sravanthi & M. S. Reddy. (2017) Microwave-assisted synthesis of pyrazole-based 1,2,3-triazole derivatives and evaluation of their antimicrobial activity. Russian Journal of General Chemistry 86:12, pages 2777-2784.
Crossref
Crossref
Scott J Warchal, Asier Unciti-Broceta & Neil O Carragher. (2016) Next-generation phenotypic screening. Future Medicinal Chemistry 8:11, pages 1331-1347.
Crossref
Crossref
K. Sudhakar, G. Thirupathi, A. Balakishan, S. Narsima chary & S. Ravi. (2016) Facile synthesis of novel (1-Aryl/alkyl-1H-1,2,3-triazol- 4-yl)methyl-2-bromo-4-methylthiazole-5-carboxylates by Cu(I) catalyzed click reaction. Russian Journal of General Chemistry 86:7, pages 1722-1729.
Crossref
Crossref
Xianhong Xu, Zhenyan Shi & Wenjun Li. (2016) Organocatalytic 1,3-dipolar [3+3] cycloaddition reaction of 1,2-cyclohexanedione with azides: direct access to highly substituted 1,2,3-triazoles. New Journal of Chemistry 40:8, pages 6559-6563.
Crossref
Crossref
Eder Tomás-Mendivil, Javier Francos, Rebeca González-Fernández, Pedro J. González-Liste, Javier Borge & Victorio Cadierno. (2016)
Bis(allyl)-ruthenium(
iv
) complexes with phosphinous acid ligands as catalysts for nitrile hydration reactions
. Dalton Transactions 45:34, pages 13590-13603.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
155
177
.
Wenjun Li, Xiao Zhou, Yepeng Luan & Jian Wang. (2015) Direct access to 1,4-disubstituted 1,2,3-triazoles through organocatalytic 1,3-dipolar cycloaddition reaction of α,β-unsaturated esters with azides. RSC Advances 5:108, pages 88816-88820.
Crossref
Crossref
Rathinam Ramesh & Appaswami Lalitha. (2015) PEG-assisted two-component approach for the facile synthesis of 5-aryl-1,2,4-triazolidine-3-thiones under catalyst-free conditions. RSC Advances 5:63, pages 51188-51192.
Crossref
Crossref
Sheri Cotterman-Hart. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
171
193
.
Eder Tomás-Mendivil, Rocío García-Álvarez, Cristian Vidal, Pascale Crochet & Victorio Cadierno. (2014)
Exploring Rhodium(I) Complexes [RhCl(COD)(PR
3
)] (COD = 1,5-Cyclooctadiene) as Catalysts for Nitrile Hydration Reactions in Water: The Aminophosphines Make the Difference
. ACS Catalysis 4:6, pages 1901-1910.
Crossref
Crossref
Jayavant D. Patil & Dattaprasad M. Pore. (2014) [C16MPy]AlCl3Br: an efficient novel ionic liquid for synthesis of novel 1,2,4-triazolidine-3-thiones in water. RSC Advances 4:28, pages 14314.
Crossref
Crossref
Svetlana Borukhova, Timothy Noël, Bert Metten, Eric de Vos & Volker Hessel. (2013) Solvent‐ and Catalyst‐Free Huisgen Cycloaddition to Rufinamide in Flow with a Greener, Less Expensive Dipolarophile. ChemSusChem 6:12, pages 2220-2225.
Crossref
Crossref
Se Hee Kim, Jeong Ho Lee, Hye Won Ryu, Byung Chan Lim, Jong Hee Chae, Ji Eun Choi, Yong Seoung Hwang & Ki Joong Kim. (2013) Short‐term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy. Epileptic Disorders 15:1, pages 49-54.
Crossref
Crossref
Zekiye Kural & Ali Fahir Ozer. (2012) Epileptic Encephalopathies in Adults and Childhood. Epilepsy Research and Treatment 2012, pages 1-8.
Crossref
Crossref
Danièle Bentué-Ferrer, Olivier Tribut & Marie-Clémence Verdier. (2012) Suivi thérapeutique pharmacologique du rufinamide. Therapies 67:2, pages 161-165.
Crossref
Crossref
Saima KayaniDeepa Sirsi. (2012) The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents. Journal of Central Nervous System Disease 4, pages JCNSD.S5097.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
367
380
.
Theodor W May, Rainer Boor, Bernhard Rambeck, Uwe Jürgens, Elisabeth Korn-Merker & Christian Brandt. (2011) Serum Concentrations of Rufinamide in Children and Adults With Epilepsy: The Influence of Dose, Age, and Comedication. Therapeutic Drug Monitoring 33:2, pages 214-221.
Crossref
Crossref
Victor Biton, Gregory Krauss, Blanca Vasquez-Santana, Francesco Bibbiani, Allison Mann, Carlos Perdomo & Milind Narurkar. (2010) A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures. Epilepsia, pages no-no.
Crossref
Crossref
Christopher S Wisniewski. (2017) Rufinamide: A New Antiepileptic Medication for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome. Annals of Pharmacotherapy 44:4, pages 658-667.
Crossref
Crossref
Christian E. Elger, Hermann Stefan, Allison Mann, Milind Narurkar, Yijun Sun & Carlos Perdomo. (2010) A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures. Epilepsy Research 88:2-3, pages 255-263.
Crossref
Crossref
Donald J. AbrahamRosaria Gitto, Laura De Luca & Giovanbattista De Sarro. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
121
160
.
Susan W. Lee & Steve S. Chung. 2010. Atlas of Epilepsies. Atlas of Epilepsies
1829
1836
.
Martin J. Brodie, William E. Rosenfeld, Blanca Vazquez, Rajesh Sachdeo, Carlos Perdomo, Allison Mann & Santiago Arroyo. (2009) Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial. Epilepsia 50:8, pages 1899-1909.
Crossref
Crossref
W. Donald Shields. (2008) Children get their due. Neurology 70:21, pages 1946-1947.
Crossref
Crossref
Shridhar Hegde & Michelle Schmidt. 2008.
455
497
.